Leukemia Channel
Topics
Medications
Quicklinks
Related Channels
Campath and CLL
Interested in a Discount on Campath?
Enter your email address to see if eMedTV's free DiscountRx service has a program that could help you save on your prescription(s).
Thank you!
Thank you for your interest in DiscountRx from eMedTV. An email has been sent to the address you provided. Please follow the link within that email to see what offers may be available.
The prescription drug Campath® (alemtuzumab) is licensed to treat a type of leukemia known as B-cell chronic lymphocytic leukemia (B-CLL). It comes as an injection that is given for 12 weeks.
Campath belongs to a group of drugs called monoclonal antibodies, which means it is approved for use alone (as a single agent) to treat people with B-CLL. It may reduce symptoms of leukemia and extend the time a person is able to live without their condition getting worse. Some people may experience a complete disappearance of their leukemia symptoms. However, not everyone will respond to the medication in the same way.
(To learn more about how this drug works to treat B-CLL, click Campath Uses. This article also explains whether it can be given to children and older adults, and lists some off-label uses.)
Written by/reviewed by: Susan Lakey, PharmD, MPH, BCPP
Last reviewed by: Kristi Monson, PharmD